Cas:75898-47-4 H-DL-Phe-OtBu.HCl manufacturer & supplier

Chemical Name:H-DL-Phe-OtBu.HCl

CAS.NO:75898-47-4

Synonyms:Phenylalanine, 1,1-dimethylethyl ester, hydrochloride (1:1);tert-Butyl D-phenylalaninate hydrochloride (1:1);L-Phenylalanine tert-butyl ester hydrochloride;tert-Butyl L-phenylalaninate hydrochloride (1:1);2-Methyl-2-propanyl phenylalaninate hydrochloride (1:1);H-DL-Phe-OtBu.HCl

Molecular Formula:C₁₃H₂₀ClNO₂

Molecular Weight:257.756

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.32000

Exact Mass:257.118256

LogP:3.40040

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Phenylalanine, 1,1-dimethylethyl ester, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-DL-Phe-OtBu.HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl L-phenylalaninate hydrochloride (1:1) Use and application,H-DL-Phe-OtBu.HCl technical grade,usp/ep/jp grade.

Related News: As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured. H-DL-Phe-OtBu.HCl manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. H-DL-Phe-OtBu.HCl supplier The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. H-DL-Phe-OtBu.HCl vendor The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city. H-DL-Phe-OtBu.HCl factory However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial.